Nitric oxide delivery system
US7025869B2 · kind B2 · utility
98Cited by
29References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 28, 2002 |
| Grant date | Apr 11, 2006 |
| Priority date | — |
| Expiry date | Sep 7, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2209/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.